Neuron survival kit

The insulin growth factor 1/Akt pathway is neuroprotective in Huntington's disease and is mediated by direct phosphorylation of huntingtin.

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Huntington's disease (HD) is caused by a mutation in the protein huntingtin. Patients with HD classically show involuntary muscular movements, personality changes and ultimately dementia, but the molecular mechanism involved in the development of the disorder has been poorly understood. In June Developmental Cell, Sandrine Humbert and colleagues from Institut Curie, Centre Universitaire, Orsay, France, show that the insulin growth factor 1/Akt pathway is neuroprotective in HD and is mediated by direct phosphorylation of huntingtin (Dev Cell 2002, 2:831-837).

Humbert et al. used primary cultures of striatal neurons and observed that IGF-1 and Akt inhibit mutant huntingtin-induced cell death. In addition they observed that huntingtin is a substrate of Akt and that phosphorylation of huntingtin by Akt is crucial to mediate the neuroprotective effects of IGF-1. They also found that Akt is altered in HD patients, which would support a role for IGF-1/Akt in HD.

"Understanding the molecular basis of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA